Changsong Wang

Second People’s Hospital of Yibin

Papers

1

Total Citations

22

H-Index

1

About

Dr. Changsong Wang is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive liver surgery, particularly through comparative effectiveness studies of robotic and laparoscopic techniques. His most influential work, a meta-analysis of propensity-score matched studies comparing robotic versus laparoscopic hepatectomy, has garnered 22 citations since 2025, establishing a critical evidence base for surgical decision-making. Dr. Wang’s major contribution lies in rigorously evaluating whether robotic approaches can overcome the inherent limitations of laparoscopic liver resection, addressing a key question in modern surgical oncology. By synthesizing data from matched cohorts, he has helped clarify the relative safety and efficacy of these two advanced techniques, providing surgeons with actionable insights to optimize patient outcomes. His research is instrumental in guiding the adoption of robotic surgery in hepatobiliary practice, and his work continues to shape clinical guidelines. Dr. Wang’s dedication to evidence-based surgical innovation makes him a pivotal figure in the evolution of minimally invasive liver surgery, with his findings directly impacting operative planning and patient recovery trajectories.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Robotic <i>versus</i> laparoscopic hepatectomy: meta-analysis of propensity-score matched studies
22 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Second People’s Hospital of Yibin

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago